Legislative and Regulatory Trends

(K2) The Inflation Reduction Act: From the Outside Looking In

Friday, March 24, 2023

9:45 AM – 11:00 AM

Location: B2/3

ACPE UAN:0233-0000-23-022-L03-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Melissa Andel, MPP (she/her/hers)

Principal
CommonHealth Solutions LLC
Alexandria, VA

Moderator(s)

Carly Rodriguez, PharmD, FAMCP

Vice President & Chief Pharmacy Officer
Moda Health
Portland, OR

President Biden's Inflation Reduction Act (IRA) delivered on two key Democratic promises to voters: Medicare prescription drug price reform and capping out-of-pocket costs for Part D beneficiaries. It may be tempting to think that the IRA will have a limited impact outside of Medicare, but that is not the case. This session will be key for meeting attendees who work for both commercial plans and manufacturers to understand how the IRA is going to leave its mark outside of Medicare as well.

Learning Objectives::

At the completion of this activity, participants should be able to:

Summarize the key drug pricing provisions of the Inflation Reduction Act (IRA).
Discuss how government negotiation of prescription drug prices will impact drug pricing in the commercial sector.
Explain how government negotiation of prescription drug prices will impact the generic and biosimilar market.
Describe how the inflation penalty rebates in the Inflation Reduction Act will impact manufacturer launch pricing decisions in the future.